SAN FRANCISCO , June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Cardiac Resynchronization Therapy (CRT) Devices - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
What's New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to our digital archives and MarketGlass Research Platform
• Complimentary updates for one year

Edition: 6; Released: January 2022
Executive Pool: 10451
Companies: 42 - Players covered include Abbott Laboratories; Biotronik SE & Co. KG; Boston Scientific Corporation; LivaNova PLC; Medtronic PLC and Others.
Coverage: All major geographies and key segments
Segments: Segment (CRT-Defibrillator (CRT-D), CRT-Pacemaker (CRT-P))
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Cardiac Resynchronization Therapy (CRT) Devices Market to Reach $8.5 Billion by 2026
Amid the COVID-19 crisis, the global market for Cardiac Resynchronization Therapy (CRT) Devices estimated at US$5.7 Billion, is projected to reach a revised size of US$8.5 Billion by 2026, growing at a CAGR of 6.5% over the analysis period. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$6.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the CRT-Pacemaker (CRT-P) segment is readjusted to a revised 7.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.8 Billion in 2021, While China is Forecast to Reach $1.5 Billion by 2026
The Cardiac Resynchronization Therapy (CRT) Devices market in the U.S. is estimated at US$1.8 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2026 trailing a CAGR of 6.1% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/a-8-5-billion-global-opportunity-for-cardiac-resynchronization-therapy-crt-devices-by-2026---new-research-from-strategyr-301575585.html

SOURCE Global Industry Analysts, Inc.